Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.

Structure and pro-toxic mechanism of the human Hsp90/PPIase/Tau complex

Open access

Abstract

The molecular chaperone Hsp90 is critical for the maintenance of cellular homeostasis and represents a promising drug target. Despite increasing knowledge on the structure of Hsp90, the molecular basis of substrate recognition and pro-folding by Hsp90/co-chaperone complexes remains unknown. Here, we report the solution structures of human full-length Hsp90 in complex with the PPIase FKBP51, as well as the 280 kDa Hsp90/FKBP51 complex bound to the Alzheimer’s disease-related protein Tau. We reveal that the FKBP51/Hsp90 complex, which synergizes to promote toxic Tau oligomers in vivo, is highly dynamic and stabilizes the extended conformation of the Hsp90 dimer resulting in decreased Hsp90 ATPase activity. Within the ternary Hsp90/FKBP51/Tau complex, Hsp90 serves as a scaffold that traps the PPIase and nucleates multiple conformations of Tau’s proline-rich region next to the PPIase catalytic pocket in a phosphorylation-dependent manner. Our study defines a conceptual model for dynamic Hsp90/co-chaperone/client recognition.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-018-06880-0

Cites

78 of 78 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 FKBP51 binds to a large continuous Hsp90 surface. a Schematic representation of the toxic Hsp90/FKBP51/Tau cross-talk. b P(r) SAXS profiles show that FKBP51 and Tau bind to the extended conformation of Hsp90 dimer, even in the presence of nucleotides. c ATPase activity of Hsp90 in the presence of different co-chaperones and Tau. All measurements were performed in triplicate and error bars represent the standard error of the mean. d Methyl-TROSY spectra of Hsp90 (80 μM) in the absence (black) and presence of an equimolar ratio of unlabeled FKBP51 (orange). Two unassigned residues in the C-terminal domain of Hsp90 are marked by “C”. e Structure of the extended human Hsp90β dimer (modified from PDB id: 5fwk19). Residues affected in FKBP51 titrations are represented by spheres. Selected residues are labeled. f Consistent with nucleotide binding to the N-terminal domain of Hsp90, ADP-induced changes (spheres) in NMR signal intensities were observed in proximity to the ATP-binding pocket in Hsp90N in the presence of saturating FKBP51 concentration
Fig. 1 FKBP51 binds to a large continuous Hsp90 surface. a Schematic representation of the toxic Hsp90/FKBP51/Tau cross-talk. b P(r) SAXS profiles show that FKBP51 and Tau bind to the extended conformation of Hsp90 dimer, even in the presence of nucleotides. c ATPase activity of Hsp90 in the presence of different co-chaperones and Tau. All measurements were performed in triplicate and error bars represent the standard error of the mean. d Methyl-TROSY spectra of Hsp90 (80 μM) in the absence (black) and presence of an equimolar ratio of unlabeled FKBP51 (orange). Two unassigned residues in the C-terminal domain of Hsp90 are marked by “C”. e Structure of the extended human Hsp90β dimer (modified from PDB id: 5fwk19). Residues affected in FKBP51 titrations are represented by spheres. Selected residues are labeled. f Consistent with nucleotide binding to the N-terminal domain of Hsp90, ADP-induced changes (spheres) in NMR signal intensities were observed in proximity to the ATP-binding pocket in Hsp90N in the presence of saturating FKBP51 concentrationCC BY · PubMed Central
Fig. 2 Dynamic nature of the interaction of FKBP51 with Hsp90. a–d Methyl-TROSY spectra of leucine-valine labeled full-length human FKBP51 (100 μM) in the absence (black) and presence of increasing concentrations of unlabeled Hsp90. FKBP51:Hsp90 molar ratios are indicated (related to monomeric Hsp90). Although TPR residues were not sequence specifically assigned, isolated TPR cross-peaks can be identified through comparison with the complete assignment of FK1–FK2. e Residue-specific changes in the intensity of FKBP51 Leu/Val methyl groups observed in a–d. I is the cross peak intensity of samples with FKBP51:Hsp90 molar ratios of 1:2 (blue), 1:4 (orange), and 1:5 (yellow). I0 is the intensity of NMR signals of FKBP51 in the absence of Hsp90. Error bars were calculated based on NMR signal-to-noise ratio. TPR residues (Leu/Val) located at the MEEVD-binding site (PDB id: 5njx) were included into the analysis. f FKBP51 residues, which were strongly perturbed by Hsp90, are shown as spheres in the 3D structure (PDB id: 1kt0). The PPIase catalytic pocket in FK1 is marked in yellow. Selected residues in the FK1 and FK2 domains are labeled. g Domain-specific changes in NMR signal intensities of FKBP51 methyl groups observed at increasing Hsp90 concentrations. I/I0 ratios were averaged over residues belonging to individual domains. Error bars represent SD. h Stopped-flow fluorescence-binding assays show that removal of FK1 (i.e., use of FK2-TPR) accelerates the rate of Hsp90 binding (ΔFFK2TPR = 0.0027 ± 0.0001 s−1; ΔFFKBP51 = 0.0021 ± 0.0003 s−1). FK1–FK2, which lacks TPR repeats, showed no binding to Hsp90. i Schematic representation of domain-specific formation of the Hsp90/FKBP51 complex
Fig. 2 Dynamic nature of the interaction of FKBP51 with Hsp90. a–d Methyl-TROSY spectra of leucine-valine labeled full-length human FKBP51 (100 μM) in the absence (black) and presence of increasing concentrations of unlabeled Hsp90. FKBP51:Hsp90 molar ratios are indicated (related to monomeric Hsp90). Although TPR residues were not sequence specifically assigned, isolated TPR cross-peaks can be identified through comparison with the complete assignment of FK1–FK2. e Residue-specific changes in the intensity of FKBP51 Leu/Val methyl groups observed in a–d. I is the cross peak intensity of samples with FKBP51:Hsp90 molar ratios of 1:2 (blue), 1:4 (orange), and 1:5 (yellow). I0 is the intensity of NMR signals of FKBP51 in the absence of Hsp90. Error bars were calculated based on NMR signal-to-noise ratio. TPR residues (Leu/Val) located at the MEEVD-binding site (PDB id: 5njx) were included into the analysis. f FKBP51 residues, which were strongly perturbed by Hsp90, are shown as spheres in the 3D structure (PDB id: 1kt0). The PPIase catalytic pocket in FK1 is marked in yellow. Selected residues in the FK1 and FK2 domains are labeled. g Domain-specific changes in NMR signal intensities of FKBP51 methyl groups observed at increasing Hsp90 concentrations. I/I0 ratios were averaged over residues belonging to individual domains. Error bars represent SD. h Stopped-flow fluorescence-binding assays show that removal of FK1 (i.e., use of FK2-TPR) accelerates the rate of Hsp90 binding (ΔFFK2TPR = 0.0027 ± 0.0001 s−1; ΔFFKBP51 = 0.0021 ± 0.0003 s−1). FK1–FK2, which lacks TPR repeats, showed no binding to Hsp90. i Schematic representation of domain-specific formation of the Hsp90/FKBP51 complexCC BY · PubMed Central
Fig. 3 Head-to-head topology of the 280 kDa Hsp90/FKBP51 complex. a–c Structural model of the Hsp90/FKBP51 complex derived from a combination of structural and biochemical data. Hsp90 is colored gray, and FKBP51 in blue. Insets in b show intermolecular contacts, for which Hsp90/FKBP51-specific NOEs were detected. R391 (red) is critical for Hsp90's ATPase activity. The charged linker (CL) is represented as a gray dotted line in c, and Hsp90M's projecting loop is colored yellow. d PRE-induced signal broadening of FKBP51 moieties upon binding to Hsp90 tagged with MTSL at position 362. Intensity ratios for TPR cross-peaks are shown for comparison (gray), but were not sequence specifically assigned (i.e., placed at random positions in the plot within the MEEVD-binding region). Error bars were calculated based on NMR signal-to-noise ratio. Threshold (yellow line) was set to 0.6. e FKBP51 residues undergoing strongest PREs (below threshold in d) are represented in yellow spheres and are located in FK1 within 25 Å to the MTSL spin center, validating the structural model. Orange spheres mark FK2 residues with close-to-threshold PRE broadening (d). f, g PCSs experienced by Hsp90 moieties upon binding to FKBP51, which was labeled with a single CLaNP-7 lanthanide tag on FK1 (at positions C107–C110). The orientation of the lanthanide tensor (red and blue shadows in f) fits well with the experimental signs of PCSs (in red and blue spheres in f and bars in g). Red dotted lines in g represent 1.5 times the SD of the averaged chemical shift changes and are used as a threshold
Fig. 3 Head-to-head topology of the 280 kDa Hsp90/FKBP51 complex. a–c Structural model of the Hsp90/FKBP51 complex derived from a combination of structural and biochemical data. Hsp90 is colored gray, and FKBP51 in blue. Insets in b show intermolecular contacts, for which Hsp90/FKBP51-specific NOEs were detected. R391 (red) is critical for Hsp90's ATPase activity. The charged linker (CL) is represented as a gray dotted line in c, and Hsp90M's projecting loop is colored yellow. d PRE-induced signal broadening of FKBP51 moieties upon binding to Hsp90 tagged with MTSL at position 362. Intensity ratios for TPR cross-peaks are shown for comparison (gray), but were not sequence specifically assigned (i.e., placed at random positions in the plot within the MEEVD-binding region). Error bars were calculated based on NMR signal-to-noise ratio. Threshold (yellow line) was set to 0.6. e FKBP51 residues undergoing strongest PREs (below threshold in d) are represented in yellow spheres and are located in FK1 within 25 Å to the MTSL spin center, validating the structural model. Orange spheres mark FK2 residues with close-to-threshold PRE broadening (d). f, g PCSs experienced by Hsp90 moieties upon binding to FKBP51, which was labeled with a single CLaNP-7 lanthanide tag on FK1 (at positions C107–C110). The orientation of the lanthanide tensor (red and blue shadows in f) fits well with the experimental signs of PCSs (in red and blue spheres in f and bars in g). Red dotted lines in g represent 1.5 times the SD of the averaged chemical shift changes and are used as a thresholdCC BY · PubMed Central
Fig. 4 Phosphorylation-dependent complexation of Tau. a Binding affinity of Tau to Hsp90 is slightly decreased by the presence of FKBP51. Reported are average values of triplicate experiments ± SD. b The dynamic complex formed by Hsp90/Tau dissociates on the SEC column. c The presence of FKBP51 stabilizes the ternary complex. Fractions corresponding to the ternary complex (represented by asterisks) were submitted to SDS-PAGE showing the presence of the three proteins in the Hsp90/FKBP51/Tau and Hsp90/FKBP51/K32 ternary complexes. Note that FKBP51 and 441-residue Tau co-migrate in the gel resulting in overlapping bands on SDS-PAGE. Both full-length Tau and the K32 fragment16 were used, to illustrate the reproducibility of the results. MALS fittings for molecular weight estimation are indicated. Note that Tau retention times are comparable to those of much larger proteins, due to its disordered structure. The uncropped gel is shown in Supplementary Figure 8. d NMR interaction profiles of 441-residue Tau with Hsp90 (orange; Tau/Hsp90 molar ratio of 1:2), FKBP51 (bottom; Tau/FKBP51 molar ratio of 1:5) and the Hsp90/FKBP51 complex (top). I0 and I are intensities of H–N cross-peaks of Tau in the absence and presence of the binding partner, respectively. For comparison, the binding pattern to Hsp90 is represented in the Tau/FKBP51 and Tau/Hsp90/FKBP51 plots by orange lines. The region covered by K32 fragment is shown on top. e Hydrophobic residues (green) in the N/M domains of Hsp90. f PREs induced in Hsp90 domains (red) by binding of Tau tagged with MTSL at position 256 within the binary Hsp90/Tau complex. g Phosphorylation of Tau impedes binding to Hsp90 and FKBP51. Cartoon representation indicating KXGS phosphorylation sites in Tau (green41), as well as sites for Ser-Thr pseudo-phosphorylation detected by AT8, AT100, and PHF1 antibodies (purple42). h NMR binding plots of Ser-Thr pseudo-phosphorylated (purple) and MARK2-phosphorylated (green) Tau to Hsp90 (left) and FKBP51 (right). For comparison, the binding profiles of wild-type Tau (dotted lines) are shown
Fig. 4 Phosphorylation-dependent complexation of Tau. a Binding affinity of Tau to Hsp90 is slightly decreased by the presence of FKBP51. Reported are average values of triplicate experiments ± SD. b The dynamic complex formed by Hsp90/Tau dissociates on the SEC column. c The presence of FKBP51 stabilizes the ternary complex. Fractions corresponding to the ternary complex (represented by asterisks) were submitted to SDS-PAGE showing the presence of the three proteins in the Hsp90/FKBP51/Tau and Hsp90/FKBP51/K32 ternary complexes. Note that FKBP51 and 441-residue Tau co-migrate in the gel resulting in overlapping bands on SDS-PAGE. Both full-length Tau and the K32 fragment16 were used, to illustrate the reproducibility of the results. MALS fittings for molecular weight estimation are indicated. Note that Tau retention times are comparable to those of much larger proteins, due to its disordered structure. The uncropped gel is shown in Supplementary Figure 8. d NMR interaction profiles of 441-residue Tau with Hsp90 (orange; Tau/Hsp90 molar ratio of 1:2), FKBP51 (bottom; Tau/FKBP51 molar ratio of 1:5) and the Hsp90/FKBP51 complex (top). I0 and I are intensities of H–N cross-peaks of Tau in the absence and presence of the binding partner, respectively. For comparison, the binding pattern to Hsp90 is represented in the Tau/FKBP51 and Tau/Hsp90/FKBP51 plots by orange lines. The region covered by K32 fragment is shown on top. e Hydrophobic residues (green) in the N/M domains of Hsp90. f PREs induced in Hsp90 domains (red) by binding of Tau tagged with MTSL at position 256 within the binary Hsp90/Tau complex. g Phosphorylation of Tau impedes binding to Hsp90 and FKBP51. Cartoon representation indicating KXGS phosphorylation sites in Tau (green41), as well as sites for Ser-Thr pseudo-phosphorylation detected by AT8, AT100, and PHF1 antibodies (purple42). h NMR binding plots of Ser-Thr pseudo-phosphorylated (purple) and MARK2-phosphorylated (green) Tau to Hsp90 (left) and FKBP51 (right). For comparison, the binding profiles of wild-type Tau (dotted lines) are shownCC BY · PubMed Central
Fig. 5 Tau’s Pro-rich region targets to the catalytic site in the complex. a, c Isoleucine residues (yellow spheres) in Hsp90, which experience paramagnetic broadening by Tau tagged with MTSL at position 178 in the Hsp90/Tau complex (a) and the Hsp90/FKBP51/Tau complex (c). Hsp90 dimer is colored in gray, and FKBP51 in blue. Tau’s domain organization is shown on top. b, d Representative ensembles of Tau conformations bound to Hsp90 (b) and the Hsp90/FKBP51 complex (d), which are in agreement with experimental intermolecular contacts. Twelve lowest-energy conformers are shown. Tau’s proline-rich region (yellow) is targeted to the PPIase catalytic pocket of FKBP51 in the Hsp90/FKBP51/Tau complex. Tau’s microtubule-binding domain is colored red. For clarity, Tau regions outside of the proline-rich domain and the MBD, which contribute little to the interaction, are not shown
Fig. 5 Tau’s Pro-rich region targets to the catalytic site in the complex. a, c Isoleucine residues (yellow spheres) in Hsp90, which experience paramagnetic broadening by Tau tagged with MTSL at position 178 in the Hsp90/Tau complex (a) and the Hsp90/FKBP51/Tau complex (c). Hsp90 dimer is colored in gray, and FKBP51 in blue. Tau’s domain organization is shown on top. b, d Representative ensembles of Tau conformations bound to Hsp90 (b) and the Hsp90/FKBP51 complex (d), which are in agreement with experimental intermolecular contacts. Twelve lowest-energy conformers are shown. Tau’s proline-rich region (yellow) is targeted to the PPIase catalytic pocket of FKBP51 in the Hsp90/FKBP51/Tau complex. Tau’s microtubule-binding domain is colored red. For clarity, Tau regions outside of the proline-rich domain and the MBD, which contribute little to the interaction, are not shownCC BY · PubMed Central
Fig. 6 The ternary complex allows asymmetric Hsp90/co-chaperone interactions. a, b The Tau-binding interface on the Hsp90 surface is largely distinct from the binding sites of FKBP51 and other co-chaperones, which in turn do not overlap. PDB codes are: human Cdc37 (PDB id: 5fwk), Arabidopsis thaliana Sgt1 (PDB id: 2xcm), yeast p23 (PDB id: 2cg9), and yeast Aha1 (PDB id: 1usv). FKBP51's catalytic PPIase pocket, which is located in the FK1 domain, is highlighted in red
Fig. 6 The ternary complex allows asymmetric Hsp90/co-chaperone interactions. a, b The Tau-binding interface on the Hsp90 surface is largely distinct from the binding sites of FKBP51 and other co-chaperones, which in turn do not overlap. PDB codes are: human Cdc37 (PDB id: 5fwk), Arabidopsis thaliana Sgt1 (PDB id: 2xcm), yeast p23 (PDB id: 2cg9), and yeast Aha1 (PDB id: 1usv). FKBP51's catalytic PPIase pocket, which is located in the FK1 domain, is highlighted in redCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 78 references

Cited by

See all 100

Metadata

Authors
Oroz, J., Chang, B. J., Wysoczanski, P., Lee, C.-T., Pérez-Lara, Á., Chakraborty, P., Hofele, R. V., Baker, J. D., Blair, L. J., Biernat, J., Urlaub, H., Mandelkow, E., Dickey, C. A., & Zweckstetter, M.
Affiliations
  • Consejo Superior de Investigaciones Científicas (ES)
  • Max Planck Institute for Biophysical Chemistry (DE)
  • German Center for Neurodegenerative Diseases (DE)
  • University of South Florida (US)
  • Center of Advanced European Studies and Research (DE)
  • Universitätsmedizin Göttingen (DE)
Corresponding author
Zweckstetter, Markus
Venue
Nature Communications
Published
2018-10-31
Volume
9
Issue
1
Pages
4532-4532
ISSN
2041-1723 (ISSN-L)
OpenAlex
W2898525239
Cited by
100
References
78
Citations by year
2026: 10 · 2025: 18 · 2024: 5 · 2023: 19 · 2022: 17 · 2021: 8 · 2020: 12 · 2019: 9 · 2018: 2
FWCI
2.83
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Communications (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • DZNE Pub (submittedVersion, cc-by)
  • GoeScholar The Publication Server of the Georg-August-Universität Göttingen (Georg-August-Universität Göttingen) (submittedVersion, cc-by)
  • MPG.PuRe (Max Planck Society) (submittedVersion, cc-by)
  • MPG.PuRe (Max Planck Society) (submittedVersion, other-oa)
  • MPG.PuRe (Max Planck Society) (submittedVersion)
Funders
  • EC | European Research Council (787679 - LLPS-NMR)
  • Deutsche Forschungsgemeinschaft (SFB860/B2, SFB860/A10)
  • U.S. Department of Health & Human Services | National Institutes of Health (R01 NS073899, R01 MH103848)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
Keywords
HSP90, FKBP51, tau protein, molecular chaperones, substrate recognition, tau oligomers, Alzheimer's disease, ATPase activity, conformational dynamics, proline-rich region, phosphorylation, co-chaperones, solution structure
MeSH terms
Tacrolimus Binding Protein 5, Humans, Models, Molecular, Magnetic Resonance Spectroscopy, Phosphorylation, Protein Binding, Protein Conformation, tau Proteins, HSP90 Heat-Shock Proteins, Tacrolimus Binding Proteins, Biocatalysis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Structure and pro-toxic mechanism of the human Hsp90/PPIase/Tau complex. https://app.cochat.ai/papers/10.1038/s41467-018-06880-0
The paper
Oroz, J., Chang, B. J., Wysoczanski, P., Lee, C.-T., Pérez-Lara, Á., Chakraborty, P., Hofele, R. V., Baker, J. D., Blair, L. J., Biernat, J., Urlaub, H., Mandelkow, E., Dickey, C. A., & Zweckstetter, M. (2018). Structure and pro-toxic mechanism of the human Hsp90/PPIase/Tau complex. Nature Communications. https://doi.org/10.1038/s41467-018-06880-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.